NCT01099306

Brief Summary

This study devised an experimental focused pharmaceutical care program, allowed a clinical pharmacist to work in a physician office to assess and manage patients' metabolic syndrome status and its individual components. This study described the clinical benefits of physician- clinical pharmacist interaction in achieving improved glycemic control, lipid and blood pressure measurements, involving medication, diet, physical activity and patient heath care counseling.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
199

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Mar 2009

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2009

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2009

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2009

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

April 5, 2010

Completed
1 day until next milestone

First Posted

Study publicly available on registry

April 6, 2010

Completed
Last Updated

April 6, 2010

Status Verified

March 1, 2009

Enrollment Period

8 months

First QC Date

April 5, 2010

Last Update Submit

April 5, 2010

Conditions

Outcome Measures

Primary Outcomes (1)

  • Improvements in metabolic syndrome status over the course of this study and absolute mean improvements in individual MS components.

    Primary outcomes were specified as: * Fasting blood glucose \< 110 mg/dl. * Body weight BMI \< 25 kg/m2. * Waist circumference ≤ 102 cm (40 in) in men and ≤ 88 cm (35 inches) in women. * Serum triglycerides \< 150 mg/dl. * HDL cholesterol ≥40mg/dl in men and ≥50mg/dl in women. * Blood pressure \< 130/85 mm Hg or \< 130/80 mm Hg when patients were diabetic.

    6 monthS

Study Arms (2)

intervention

ACTIVE COMPARATOR

pharmacist-physician collaborative approach to manage Metabolic syndrome

Other: Pharmaceutical care services

control

NO INTERVENTION

physician only team to manage Metabolic syndrome

Interventions

Patients' metabolic components were assessed and managed collaboratively by focused care plan designed by the clinical pharmacist and approved by the physician.Pharmacist emphasized the change in lifestyle, particularly weight loss and physical activity as a first line therapy for at least 3 months, patients were started on drug therapy when needed as recommended by clinical guidelines.

intervention

Eligibility Criteria

Age32 Years - 88 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Meeting at least 3 of the 5 criteria for the National Cholesterol Education Program Adult Treatment Panel III (NCEP/ATPIII) for the diagnosis of Metabolic syndrome upon the time of enrollment. :
  • Abdominal circumference \>102 cm in males or \>88 cm in females.
  • HDL cholesterol \< 40 mg/dl for males or \< 50 mg/dl for females.
  • Triglycerides ≥ 150 mg/dl.
  • Blood pressure ≥ 130/85 mmHg or receiving hypertension treatment.
  • Baseline glycemia ≥ 110 mg/dl.

You may not qualify if:

  • Patients with hypertensive urgency or emergency with BP more than (180/110).
  • Patients with recent stroke or myocardial infraction (within past 6 months).
  • Patients with Class III or IV Chronic heart Failure (CHF).
  • Patients with Unstable angina.
  • Patients with Serious renal or hepatic disease.
  • Pregnant patients.
  • Patients with Dementia or cognitive impairment.
  • If the patient is unable to provide informed written consent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

family medicine clinic JUH

Amman, Amman Governorate, 13046, Jordan

Location

MeSH Terms

Conditions

Metabolic Syndrome

Interventions

Pharmaceutical Services

Condition Hierarchy (Ancestors)

Insulin ResistanceHyperinsulinismGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic Diseases

Intervention Hierarchy (Ancestors)

Health ServicesHealth Care Facilities Workforce and Services

Study Officials

  • Eman Hammad, MSc

    University of Jordan/ Faculty of Pharmacy

    PRINCIPAL INVESTIGATOR
  • Abla Al bsoul, PhD

    University of Jordan/ Faculty of Pharmacy

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
CARE PROVIDER
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
OTHER

Study Record Dates

First Submitted

April 5, 2010

First Posted

April 6, 2010

Study Start

March 1, 2009

Primary Completion

November 1, 2009

Study Completion

November 1, 2009

Last Updated

April 6, 2010

Record last verified: 2009-03

Locations